Linear immunoglobulin a bullous disease of childhood responsive to intravenous immunoglobulin monotherapy.

Abstract

We report a case of linear immunoglobulin A bullous disease in a 9-year-old boy who presented with rapidly progressive severe disease and could not tolerate dapsone because of high liver enzymes within a week after a low dose of dapsone in association with an underlying fatty liver. He showed remarkable improvement with intravenous immunoglobulins used as monotherapy, with a rapid clearance and a sustained remission after stopping the treatment.

DOI: 10.1111/j.1525-1470.2011.01475.x

Cite this paper

@article{Nanda2012LinearIA, title={Linear immunoglobulin a bullous disease of childhood responsive to intravenous immunoglobulin monotherapy.}, author={Arti Nanda and Fatima Khawaja and Mousmee Nanda and Humoud Al-Sabah and Mohamed Selim and Richard Dvorak and Qasem A Alsaleh}, journal={Pediatric dermatology}, year={2012}, volume={29 4}, pages={529-32} }